Loading company…
Riskpilot
← Back to search
Sign in
Get full access
RB af 31-5-2018 ApS
APS
In liquidation
CVR 39615363
Johannevej 20
Manufacture of pharmaceutical preparations · NACE 2120
Est. 2018
1 employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2018
DKK -174K
EBITDA margin
784.4%
Equity ratio
-1427.0%
Financial strength
Net profit 2018
DKK -1,4M
EBITDA — year on year
DKK millions
0M
-0M
-1M
-1M
-1M
-1M
2018
Key figures
Annual report 2018
Revenue
DKK -174K
—
EBITDA
DKK -1,4M
—
Net profit
DKK -1,4M
—
Total assets
DKK 93K
—
Equity
DKK -1,3M
—
Employees
—
—
Company information
Legal name
RB af 31-5-2018 ApS
CVR number
39615363
Legal form
Anpartsselskab
NACE code
2120 · Manufacture of pharmaceutical preparations
Founded
31. maj 2018
Share capital
DKK 50.000
Employees
1
VAT registered
No
Audit selected
No
Last report
2018-12-31
Financial year
January – December
Signatory rights
Virksomheden tegnes af en likvidator
Contact
Address
Johannevej 20
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Manufacture of pharmaceutical preparations
Companies in Hørsholm
All Denmark companies
Revenue
DKK millions
0M
0M
1M
1M
1M
0M
2018
EBITDA
DKK millions
0M
-0M
-1M
-1M
-1M
-1M
2018
Income statement
DKK thousands
Item
2018
Revenue
-174
Staff expenses
-1.194
EBITDA
-1.369
Depreciation & amort.
-0
EBIT
-1.369
Net financials
-6
Profit before tax
-1.375
Tax
-0
Net profit
-1.375
Balance sheet
DKK thousands
Item
2018
Total assets
93
Equity
-1.325
Long-term debt
0
Short-term debt
1.418
Total debt
1.418
Financial ratios
5-year trend
EBITDA margin
-136868800.0%
This company
15.8%
Market median
-866258328% vs market
2018
2018
Equity ratio
-1427.0%
This company
38.2%
Market median
-3836% vs market
2018
2018
Return on equity
-137514300.0%
This company
18.4%
Market median
-747360426% vs market
2018
2018
Net profit margin
-137514300.0%
This company
8.1%
Market median
-1697707507% vs market
2018
2018
Asset turnover
-1.88×
This company
1.12×
Market median
-268% vs market
2018
2018
Debt / equity
1.07×
This company
0.62×
Market median
-73% vs market
2018
2018
Annual reports & filings
Annual report 2018
Filed via CVR / Virk · Period 2018-05-31 – 2018-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Age
Other directorships
BW
Bin Wang
Chairman
2018
—
—
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Peter Halkjær-Knudsen
Individual
100.0%
100.0%
2018
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of RB af 31-5-2018 ApS also hold positions in
0
other companies.
Person
Role here
Other companies
Bin Wang
Chairman
0 companies